DWOCX
Price
$12.77
Change
-$0.06 (-0.47%)
Updated
Apr 17 closing price
Net Assets
1.35B
RGAFX
Price
$66.23
Change
+$0.05 (+0.08%)
Updated
Apr 17 closing price
Net Assets
261.04B
Ad is loading...

DWOCX vs RGAFX

Header iconDWOCX vs RGAFX Comparison
Open Charts DWOCX vs RGAFXBanner chart's image
BNY Mellon Research Growth C
Price$12.77
Change-$0.06 (-0.47%)
VolumeN/A
Net Assets1.35B
American Funds Growth Fund of Amer R5
Price$66.23
Change+$0.05 (+0.08%)
VolumeN/A
Net Assets261.04B
DWOCX vs RGAFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DWOCX vs. RGAFX commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DWOCX is a Hold and RGAFX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RGAFX has more cash in the bank: 261B vs. DWOCX (1.35B). RGAFX pays higher dividends than DWOCX: RGAFX (0.66) vs DWOCX (0.00). DWOCX was incepted earlier than RGAFX: DWOCX (17 years) vs RGAFX (23 years). DWOCX (1.93) is less costly to investors than RGAFX (0.34). RGAFX is a more actively managed with annual turnover of: 25.00 vs. DWOCX (21.26). RGAFX has a lower initial minimum investment than DWOCX: RGAFX (250) vs DWOCX (1000). RGAFX annual gain was more profitable for investors over the last year : -2.56 vs. DWOCX (-7.56). RGAFX return over 5 years is better than : 38.67 vs. DWOCX (-2.21).
DWOCXRGAFXDWOCX / RGAFX
Total Expense Ratio1.780.34524%
Annual Report Gross Expense Ratio1.930.34568%
Fund Existence17 years23 years-
Gain YTD-17.492-11.005159%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.35B261B1%
Annual Yield % from dividends0.000.66-
Returns for 1 year-7.56-2.56295%
Returns for 3 years-14.755.92-249%
Returns for 5 years-2.2138.67-6%
Returns for 10 years-7.1649.66-14%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLRB0.300.02
+5.58%
Cellectar Biosciences
DSGN3.500.12
+3.55%
Design Therapeutics
CDW151.472.70
+1.81%
CDW Corp
TXNM53.400.83
+1.58%
TXNM Energy Inc
EVRI13.770.02
+0.15%
Everi Holdings